Selected research
Industry Research
Epigenetics NGS Service Industry Research Report 2026
Market perspective
The global Epigenetics NGS Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Epigenetics NGS Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Epigenetics NGS Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Epigenetics NGS Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Epigenetics NGS Service include Active Motif, Agilent, Zymo Research, Celemics, EpiGentek, GENEWIZ from Azenta, Thermo Fisher Scientific, GenomeScan and Hologic Diagenode, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Epigenetics NGS Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Epigenetics NGS Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epigenetics NGS Service Market by Company
Active Motif
Agilent
Zymo Research
Celemics
EpiGentek
GENEWIZ from Azenta
Thermo Fisher Scientific
GenomeScan
Hologic Diagenode
Illumina
Macrogen
Novogene
Roche Sequencing Solutions
SeqMatic
Epigenetics NGS Service Segment by Type
DNA Methylation Sequencing
Histone Modification Sequencing
3D Genome Sequencing
Others
Epigenetics NGS Service Segment by Application
Clinical Diagnostics
Basic Research
Drug Development
Agricultural Breeding
Others
Epigenetics NGS Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics NGS Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigenetics NGS Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics NGS Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Epigenetics NGS Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation Sequencing
- Histone Modification Sequencing
- 3D Genome Sequencing
- Others
Applications
- Clinical Diagnostics
- Basic Research
- Drug Development
- Agricultural Breeding
- Others
Companies covered
- Active Motif
- Agilent
- Zymo Research
- Celemics
- EpiGentek
- GENEWIZ from Azenta
- Thermo Fisher Scientific
- GenomeScan
- Hologic Diagenode
- Illumina
- Macrogen
- Novogene
- Roche Sequencing Solutions
- SeqMatic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Epigenetics NGS Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Methylation Sequencing
- 2.2.3 Histone Modification Sequencing
- 2.2.4 3D Genome Sequencing
- 2.2.5 Others
- 2.3 Epigenetics NGS Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnostics
- 2.3.3 Basic Research
- 2.3.4 Drug Development
- 2.3.5 Agricultural Breeding
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Epigenetics NGS Service Breakdown Data by Type
- 3.1 Global Epigenetics NGS Service Historic Market Size by Type (2021-2026)
- 3.2 Global Epigenetics NGS Service Forecasted Market Size by Type (2027-2032)
4 Epigenetics NGS Service Breakdown Data by Application
- 4.1 Global Epigenetics NGS Service Historic Market Size by Application (2021-2026)
- 4.2 Global Epigenetics NGS Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Epigenetics NGS Service Market Perspective (2021-2032)
- 5.2 Global Epigenetics NGS Service Growth Trends by Region
- 5.2.1 Global Epigenetics NGS Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Epigenetics NGS Service Historic Market Size by Region (2021-2026)
- 5.2.3 Epigenetics NGS Service Forecasted Market Size by Region (2027-2032)
- 5.3 Epigenetics NGS Service Market Dynamics
- 5.3.1 Epigenetics NGS Service Industry Trends
- 5.3.2 Epigenetics NGS Service Market Drivers
- 5.3.3 Epigenetics NGS Service Market Challenges
- 5.3.4 Epigenetics NGS Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Epigenetics NGS Service Players by Revenue
- 6.1.1 Global Top Epigenetics NGS Service Players by Revenue (2021-2026)
- 6.1.2 Global Epigenetics NGS Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Epigenetics NGS Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Epigenetics NGS Service Head Office and Area Served
- 6.4 Global Epigenetics NGS Service Players, Product Type & Application
- 6.5 Global Epigenetics NGS Service Manufacturers Established Date
- 6.6 Global Epigenetics NGS Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Epigenetics NGS Service Market Size (2021-2032)
- 7.2 North America Epigenetics NGS Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Epigenetics NGS Service Market Size by Country (2021-2026)
- 7.4 North America Epigenetics NGS Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Epigenetics NGS Service Market Size (2021-2032)
- 8.2 Europe Epigenetics NGS Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Epigenetics NGS Service Market Size by Country (2021-2026)
- 8.4 Europe Epigenetics NGS Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Epigenetics NGS Service Market Size (2021-2032)
- 9.2 Asia-Pacific Epigenetics NGS Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Epigenetics NGS Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Epigenetics NGS Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Epigenetics NGS Service Market Size (2021-2032)
- 10.2 South America Epigenetics NGS Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Epigenetics NGS Service Market Size by Country (2021-2026)
- 10.4 South America Epigenetics NGS Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Epigenetics NGS Service Market Size (2021-2032)
- 11.2 Middle East & Africa Epigenetics NGS Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Epigenetics NGS Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Epigenetics NGS Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Active Motif
- 12.1.1 Active Motif Company Information
- 12.1.2 Active Motif Business Overview
- 12.1.3 Active Motif Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.1.4 Active Motif Epigenetics NGS Service Product Portfolio
- 12.1.5 Active Motif Recent Developments
- 12.2 Agilent
- 12.2.1 Agilent Company Information
- 12.2.2 Agilent Business Overview
- 12.2.3 Agilent Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.2.4 Agilent Epigenetics NGS Service Product Portfolio
- 12.2.5 Agilent Recent Developments
- 12.3 Zymo Research
- 12.3.1 Zymo Research Company Information
- 12.3.2 Zymo Research Business Overview
- 12.3.3 Zymo Research Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.3.4 Zymo Research Epigenetics NGS Service Product Portfolio
- 12.3.5 Zymo Research Recent Developments
- 12.4 Celemics
- 12.4.1 Celemics Company Information
- 12.4.2 Celemics Business Overview
- 12.4.3 Celemics Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.4.4 Celemics Epigenetics NGS Service Product Portfolio
- 12.4.5 Celemics Recent Developments
- 12.5 EpiGentek
- 12.5.1 EpiGentek Company Information
- 12.5.2 EpiGentek Business Overview
- 12.5.3 EpiGentek Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.5.4 EpiGentek Epigenetics NGS Service Product Portfolio
- 12.5.5 EpiGentek Recent Developments
- 12.6 GENEWIZ from Azenta
- 12.6.1 GENEWIZ from Azenta Company Information
- 12.6.2 GENEWIZ from Azenta Business Overview
- 12.6.3 GENEWIZ from Azenta Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.6.4 GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio
- 12.6.5 GENEWIZ from Azenta Recent Developments
- 12.7 Thermo Fisher Scientific
- 12.7.1 Thermo Fisher Scientific Company Information
- 12.7.2 Thermo Fisher Scientific Business Overview
- 12.7.3 Thermo Fisher Scientific Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.7.4 Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio
- 12.7.5 Thermo Fisher Scientific Recent Developments
- 12.8 GenomeScan
- 12.8.1 GenomeScan Company Information
- 12.8.2 GenomeScan Business Overview
- 12.8.3 GenomeScan Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.8.4 GenomeScan Epigenetics NGS Service Product Portfolio
- 12.8.5 GenomeScan Recent Developments
- 12.9 Hologic Diagenode
- 12.9.1 Hologic Diagenode Company Information
- 12.9.2 Hologic Diagenode Business Overview
- 12.9.3 Hologic Diagenode Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.9.4 Hologic Diagenode Epigenetics NGS Service Product Portfolio
- 12.9.5 Hologic Diagenode Recent Developments
- 12.10 Illumina
- 12.10.1 Illumina Company Information
- 12.10.2 Illumina Business Overview
- 12.10.3 Illumina Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.10.4 Illumina Epigenetics NGS Service Product Portfolio
- 12.10.5 Illumina Recent Developments
- 12.11 Macrogen
- 12.11.1 Macrogen Company Information
- 12.11.2 Macrogen Business Overview
- 12.11.3 Macrogen Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.11.4 Macrogen Epigenetics NGS Service Product Portfolio
- 12.11.5 Macrogen Recent Developments
- 12.12 Novogene
- 12.12.1 Novogene Company Information
- 12.12.2 Novogene Business Overview
- 12.12.3 Novogene Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.12.4 Novogene Epigenetics NGS Service Product Portfolio
- 12.12.5 Novogene Recent Developments
- 12.13 Roche Sequencing Solutions
- 12.13.1 Roche Sequencing Solutions Company Information
- 12.13.2 Roche Sequencing Solutions Business Overview
- 12.13.3 Roche Sequencing Solutions Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.13.4 Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio
- 12.13.5 Roche Sequencing Solutions Recent Developments
- 12.14 SeqMatic
- 12.14.1 SeqMatic Company Information
- 12.14.2 SeqMatic Business Overview
- 12.14.3 SeqMatic Revenue in Epigenetics NGS Service Business (2021-2026)
- 12.14.4 SeqMatic Epigenetics NGS Service Product Portfolio
- 12.14.5 SeqMatic Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst